Neurochemical characterization of a neuroprotective compound from Parawixia bistriata spider venom that inhibits synaptosomal uptake of GABA and Glycine

Molecular Pharmacology

Volumn 69, Issue 6, 2006, Pages 1998-2006

  Beleboni, Renê Oliveira ^a,c   Guizzo, Renato ^a   Karklin Fontana, Andréia Cristina ^b   Pizzo, Andrea Baldocchi ^a   Carolino, Ruither Oliveira Gomes ^a   Gobbo Neto, Leonardo ^a   Lopes, Norberto Peporine ^a   Coutinho Netto, Joaquim ^a   Dos Santos, Wagner Ferreira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 UREIDOPENTANAMIDE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; AMIDE; CALCIUM CHANNEL; GLUTAMATE TRANSPORTER; GLYCINE; MONOAMINE; POTASSIUM CHANNEL; SODIUM CHANNEL; SPIDER VENOM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD RETINA BARRIER; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; GLAUCOMA; MALE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PARAWIXIA BISTRIATA; PRIORITY JOURNAL; RAT; SPIDER;

ANIMALS; BIOLOGICAL TRANSPORT; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GAMMA-AMINOBUTYRIC ACID; GLAUCOMA; GLYCINE; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; ION CHANNELS; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED BB; RECEPTORS, GABA-B; RETINA; SPIDER VENOMS; SPIDERS; SYNAPTOSOMES; UREA;

EID: 33745179229     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.017319     Document Type: Article

References (36)

1. 3H]GABA in culture chick retina cells. Brain Res 655: 213-221.
2. Beleboni RO, Carolino ROG, Pizzo AB, Castellan-Baldan L, Coutinho-Netto J, Santos WF, and Coimbra NC (2004a) Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsychobiological relationships. Cell Mol Neurobiol 24:707-728.
3. Beleboni RO, Pizzo AB, Fontana AC, Carolino ROG, Coutinho-Netto J, and Santos WF (2004b) Spider and wasp neurotoxins: pharmacological and biochemical aspects. Eur J Pharmacol 16:1-17.
4. 3H]GABA release from striatal slices: evidence for a calcium-independent process via the GABA uptake system. Neuroscience 27:563-570.
5. Bicalho AF, Guatimosim C, Prado MA, Gomez MV, and Romano-Silva MA (2002) Investigation of the modulation of glutamate release by sodium channels using neurotoxins. Neuroscience 113:115-123.
6. Bormann J (2000) The 'ABC' of GABA receptors. Trends Pharmacol Sci 21:16-19.
7. Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI, and Enna SJ (2002) International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function. Pharmacol Rev 54:247-264.
8. Cairrão MAR, Ribeiro AM, Pizzo AB, Fontana ACK, Beleboni RO, Coutinho-Netto J, Miranda A, and Santos WF (2002) Anticonvulsant and GABA uptake inhibition properties of venom fractions from the spiders Parawixia bistriata and Scaptocosa raptoria. Pharm Biol 40:472-477.
9. Christensen H, Fykse EM, and Fonnum F (1991) Inhibition of γ-aminobutyrate and glycine uptake into synaptic vesicles. Eur J Pharmacol 207:73-79.
10. Eliasof S, Arriza JL, Leighton BH, Amara SG, and Kavanaugh MP (1998) Localization and function of five glutamate transporters cloned from the salamander retina. Vision Res 38:1443-1454.
11. Escoubas P, Diochot S, and Corzo G (2000) Structure and pharmacology of spider venom neurotoxins. Biochimie 82:893-907.
12. Fisher M and Bogousslavsky J (1998) Further evolution toward effective therapy for acute ischemic stroke. J Am Med Assoc 279:1298-1303.
13. Fontana AC, Cairrão MA, Colusso AJ, Santos WF, and Coutinho-Netto J (2000) Paralizing activity of the Parawixia bistriata crude venom in termites: a new bioassay. Toxicon 38:133-138.
14. Fontana AC, Guizzo R, Beleboni RO, Meirelles-Silva AR, Coimbra NC, Amara SG, Santos WF, and Coutinho-Netto J (2003) Purification of a neuroprotective compound of Parawixia bistriata spider venom that enhances glutamate uptake. Br J Pharmacol 139:1297-1309.
15. Gadea A, Lopez E, and Lopez-Colome AM (1999) Characterization of glycine transport in cultured Müller glial cells from the retina. Glia 26:273-279.
16. Gray EG and Whittaker VP (1962) The isolation of nerve ending from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat 96:79-87.
17. B receptor activation in rat supraoptic neurones. J Physiol (Lond) 509:371-383.
18. Hartree EF (1972) Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 48:422-427.
19. Harvey AL, Bradley KN, Cochran SA, Rowan EG, Pratt JA, Quillfeldt JA, and Jerusalinsky DA (1998) What can toxins tell us for drug discovery? Toxicon 36:1635-1640.
20. Hendry SH, Schwark HD, Jones EG, and Yan J (1987) Numbers and proportions of GABA-immunoreactive neurons in different areas of monkey cerebral cortex. J Neurosci 7:1503-1519.
21. Honda S, Yamamoto M, and Saito N (1995) Immunocytochemical localization of three subtypes of GABA transporter in rat retina. Brain Res Mol Brain Res 33:319-325.
22. Ichinose T and Lukasiewicz PD (2002) GABA transporters regulate inhibition in the retina by limiting GABA(C) receptor activation. J Neurosci 22:3285-3292.
23. Krogsgaard-Larsen P, Frolund BF, and Falch E (1998) Inhibitors of gamma-aminobutyric acid transport as experimental tools and therapeutic agents. Methods Enzymol 296:165-175.
24. Louzada-Junior P, Dias JJ, Santos WF, Lachat JJ, Bradford HF, and Coutinho-Netto J (1992) Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J Neurochem 59:358-363.
25. Lowry OH, Rosenbrouch NJ, Farr AL, and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
26. Meldrum BS (1997) Identification and preclinical testing of novel antiepileptic compounds. Epilepsia 38 (Suppl 9):S7-S15.
27. O'Connell AW, Fox GB, Kjoller C, Gallagher HC, Murphy KJ, Kelly J, and Regan CM (2001) Anti-ischemic and cognition-enhancing properties of NNC-711, a gamma-aminobutyric acid reuptake inhibitor. Eur J Pharmacol 424:37-44.
28. Salvador RA and Albers RW (1959) The distribution of glutamic-γ- aminobutyric transaminase in the nervous system of the rhesus monkey. J Cell Biol 6:922-925.
29. Sarup A, Larsson OM, and Schousboe A (2003) GABA transporters and GABA-transaminase as drug targets. Curr Drug Target CNS Neurol Disord 2:269-277.
30. Sherif FM and Ahmed SS (1995) Basic aspects of GABA-transaminase in neuropsychiatric disorders. Clin Biochem 28:145-154.
31. Steuer H, Jaworski A, Elger B, Kaussmann M, Keldenich J, Schneider H, Stoll D, and Schlosshauer B (2005) Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Investig Ophthalmol Vis Sci 46:1047-1053.
32. Wang SJ and Sihra TS (2003) Opposing facilitatory and inhibitory modulation of glutamate release elicited by cAMP production in cerebrocortical nerve terminals (synaptosomes). Neuropharmacology 44:686-697.
33. Wässle H, Koulen P, Brandstatter JH, Fletcher EL, and Becker CM (1998) Glycine and GABA receptors in the mammalian retina. Vision Res 38:1411-1430.
34. Wong CG, Bottiglieri T, and Snead OC 3rd (2003) GABA, gamma-hydroxybutyric acid and neurological disease. Ann Neurol 54:3-12.
35. Worrall DM and Williams DC (1994) Sodium ion-dependent transporters for neurotransmitters: a review of recent developments. Biochem J 297:425-436.
36. Zukin SR, Young AB, and Snyder SH (1974) Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. Proc Natl Acad Sci USA 71:4802-4807.